Literature DB >> 12399242

Visual loss during interferon-alpha therapy in hepatitis C virus infection.

Gabriel Perlemuter, Bahram Bodaghi, Phuc Le Hoang, Chaza Izem, Catherine Buffet, Bertrand Wechsler, Jean-Charles Piette, Patrice Cacoub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12399242     DOI： 10.1016/s0168-8278(02)00243-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

Review 1.  Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Authors:  Roderick O'Day; Mark C Gillies; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.

Authors:  Bahram Bodaghi; Gael Gendron; Bertrand Wechsler; Céline Terrada; Nathalie Cassoux; Du Le Thi Huong; Claire Lemaitre; Christine Fradeau; Phuc LeHoang; Jean-Charles Piette
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

Review 3.  Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C.

Authors:  Ji-Hua Xue; Hai-Hong Zhu; Jing Wang; Zhi Chen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

4.  Interferon-alpha2a and Vogt-Koyanagi-Harada disease: a double-edged sword?

Authors:  Valerie Touitou; Damien Sene; Christine Fardeau; Thi-Huong-Du Boutin; Pierre Duhaut; Jean-Charles Piette; Phuc LeHoang; Patrice Cacoub; Bahram Bodaghi
Journal:  Int Ophthalmol       Date:  2007-02-23       Impact factor: 2.029

Review 5.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.